NUVB Return on Tangible Equity | Nuvation Bio Inc.

Nuvation Bio Inc. (NUVB) Return on Tangible Equity

2026-06-30: Return Tang Equity -61.51%.
2026-03-31: Return Tang Equity -47.28%.
2025-12-31: Return Tang Equity -69.48%.
2025-09-30: Return Tang Equity -69.22%.

Complete source-backed return tang equity history.

Available history: 2020-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-61.51%
2026-03-31	-47.28%
2025-12-31	-69.48%
2025-09-30	-69.22%
2025-06-30	-56.24%
2025-03-31	-146.10%
2024-12-31	-123.69%
2024-09-30	-106.47%
2024-06-30	-200.86%
2024-03-31	-11.59%
2023-12-31	-12.53%
2023-09-30	-13.55%
2023-06-30	-14.47%
2023-03-31	-16.32%
2022-12-31	-15.91%
2022-09-30	-16.24%
2022-06-30	-14.90%
2022-03-31	-12.13%
2021-12-31	-11.64%
2021-09-30	-9.75%
2021-06-30	-8.12%
2021-03-31	-6.61%
2020-12-31	-19.37%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-69.48%
2024-12-31	-123.69%
2023-12-31	-12.53%
2022-12-31	-15.91%
2021-12-31	-11.64%
2020-12-31	-19.37%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
UroGen Pharma Ltd. (URGN)		$2.015B	-18.42
Biohaven Ltd. (BHVN)	United States	$1.990B	-3.83
NEKTAR THERAPEUTICS (NKTR)	United States	$2.026B	-9.05
PERRIGO Co plc (PRGO)	Ireland	$2.038B	-0.79
AGIOS PHARMACEUTICALS, INC. (AGIO)	United States	$1.962B	-5.38
Generate Biomedicines, Inc. (GENB)	United States	$2.052B
Sarepta Therapeutics, Inc. (SRPT)	United States	$1.941B	-13.89
Trevi Therapeutics, Inc. (TRVI)	United States	$2.091B	-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)	United States	$2.105B	-35.55
Braveheart Bio, Inc. (BRVE)	United States	$2.106B